Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

House member targets reprocessing

This article was originally published in The Gray Sheet

Executive Summary

Rosa DeLauro (D-Conn.) is urging more rigorous FDA oversight of reprocessed single-use devices (SUDs) in response to a Dec. 11-12 series of reports in The Washington Post questioning the safety of reprocessed SUDs. The agency should have a set number of inspectors assigned to investigate reprocessing facilities to prevent smaller operators from avoiding oversight, DeLauro suggests in a Dec. 12 statement. The Association of Medical Device Reprocessors argues the Post presented "no evidence that patients are put at an increased risk" from reprocessing...
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT023029

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel